Replies to post #192269 on Innovation Pharmaceuticals Inc (IPIX)

[Amatuer17]

If you want to see how BP sees potential and act on it - look at BL-8040

Genentech - Merck entered into collaboration and both agreed to conduct multiple trials with their leading compound - sometimes bearing full cost.

That is also in P1 - with K being on market for 4 years of trial in P1 - what progress has been made? Still trying find what it does and where to go - maybe we change formulation and start from scratch.

[Scottwny]

I'm hoping we partner up with K and start some combo trials next year. Imagine we have similar/better results to what they blogged about:

http://www.ipharminc.com/new-blog/2017/5/25/p53-gene-therapy-shows-added-efficacy-when-used-in-combination

"Laboratory studies conducted by Innovation and at leading institutions on the effects of Kevetrin in combination with approved cancer drugs, including studies against renal cancer, pancreatic cancer, ovarian cancer, glioblastoma and acute myeloid leukemia, have delivered promising data supporting the ability of Kevetrin to enhance chemosensitivity."